Early-Stage Chronic Kidney Disease and Related Health Care Spending

被引:3
|
作者
Sakoi, Naomi [2 ,3 ]
Mori, Yuichiro [3 ]
Tsugawa, Yusuke [4 ,5 ]
Tanaka, Junko [2 ]
Fukuma, Shingo [1 ,3 ]
机构
[1] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Shogoin Kawaharamachi 54,Sakyo, Kyoto 6068507, Japan
[2] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan
[3] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan
[4] David Geffen Sch Med UCLA, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA
[5] UCLA Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA
关键词
CARDIOVASCULAR-DISEASE; CKD; AWARENESS; COST; EXPENDITURES; POPULATION; OUTCOMES; TRENDS; NEED;
D O I
10.1001/jamanetworkopen.2023.51518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance The global burden of chronic kidney disease (CKD) is substantial and potentially leads to higher health care resource use.Objective To examine the association between early-stage CKD and health care spending and its changes over time in the general population.Design, Setting, and Participants Cohort study using nationwide health checkup and medical claims data in Japan. Participants included individuals aged 30 to 70 years with estimated glomerular filtration rates (eGFR) of 30 mL/min/1.73 m(2) or greater at the baseline screening in 2014. Data analyses were conducted from April 2021 to October 2023.Exposure The CKD stages at baseline, defined by the eGFR and proteinuria, were as follows: eGFR of 60 mL/min/1.73 m(2) or greater without proteinuria, eGFR of 60 mL/min/1.73 m(2) or greater with proteinuria, eGFR of 30 to 59 mL/min/1.73 m(2) without proteinuria, and eGFR of 30 to 59 mL/min/1.73 m(2) with proteinuria.Main Outcome and Measures The primary outcome was excess health care spending, defined as the absolute difference in health care spending according to the baseline CKD stages (reference group: eGFR >= 60 mL/min/1.73 m(2) without proteinuria) in the baseline year (2014) and in the following 5 years (2015 to 2019).Results Of the 79 988 participants who underwent a health checkup (mean [SD] age, 47.0 [9.4] years; 22 027 [27.5%] female), 2899 (3.6%) had an eGFR of 60 mL/min/1.73 m(2) or greater with proteinuria, 1116 (1.4%) had an eGFR of 30 to 59 mL/min/1.73 m(2) without proteinuria, and 253 (0.3%) had an eGFR of 30 to 59 mL/min/1.73 m(2) with proteinuria. At baseline, the presence of proteinuria and an eGFR less than 60 mL/min/1.73 m(2) were associated with greater excess health care spending (adjusted difference, $178; 99% CI, $6-$350 for proteinuria; $608; 99% CI, $233-$983 for an eGFR of 30-59 mL/min/1.73 m(2); and $1254; 99% CI, $134-$2373 for their combination). The study consistently found excess health care spending over the following 5 examined years.Conclusions and Relevance In this cohort study of nationwide health checkup and medical claims data in Japan, early-stage CKD was associated with excess health care spending over the 5 examined years, and the association was more pronounced with a more advanced disease stage.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Illness Representations and Coping Processes of Taiwanese Patients With Early-Stage Chronic Kidney Disease
    Lin, Chiu-Chu
    Chen, Mei-Chun
    Hsieh, Hsiu-Fang
    Chang, Shu-Chen
    JOURNAL OF NURSING RESEARCH, 2013, 21 (02) : 120 - 128
  • [22] Vitamin can improve early-stage kidney disease
    Lobnig, B. M.
    DIABETOLOGE, 2009, 5 (02): : 130 - +
  • [23] HYPERTENSION IN EARLY-STAGE KIDNEY DISEASE: AN UPDATE FROM THE KIDNEY EARLY EVALUATION PROGRAM
    Kalaitzidis, Rigas
    Li, Suying
    Wang, Changchun
    Chen, Shu-Cheng
    McCullough, Peter A.
    Bakris, George
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A45 - A45
  • [24] Preventive health care in chronic kidney disease and end-stage renal disease
    Devasmita Choudhury
    Cynthia Luna-Salazar
    Nature Clinical Practice Nephrology, 2008, 4 : 194 - 206
  • [25] Preventive health care in chronic kidney disease and end-stage renal disease
    Choudhury, Devasmita
    Luna-Salazar, Cynthia
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (04): : 194 - 206
  • [26] Effects of oral carbonic adsorbent (AST-120) on kidney of early-stage chronic kidney disease rats
    Tan, Xiao
    He, Jianqiang
    Cao, Xuesen
    Zou, Jianzhou
    Liu, Hong
    Ding, Xiaoqiang
    RENAL FAILURE, 2015, 37 (02) : 337 - 342
  • [27] Understanding tensions and identifying clinician agreement on improvements to early-stage chronic kidney disease monitoring in primary care: a qualitative study
    Simmonds, Rosemary
    Evans, Julie
    Feder, Gene
    Blakeman, Tom
    Lasserson, Dan
    Murray, Elizabeth
    Bennert, Kristina
    Locock, Louise
    Horwood, Jeremy
    BMJ OPEN, 2016, 6 (03):
  • [28] Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease
    Zhou, Y.
    Zhong, N.
    Li, Xiaochen
    Chen, S.
    Zheng, J.
    Zhao, D.
    Yao, W.
    Zhi, R.
    Wei, L.
    He, B.
    Zhang, X.
    Yang, C.
    Li, Ying
    Li, F.
    Du, J.
    Gui, J.
    Hu, B.
    Bai, C.
    Huang, P.
    Chen, G.
    Xu, Y.
    Wang, C.
    Liang, B.
    Li, Yinhuan
    Hu, G.
    Tan, H.
    Ye, X.
    Ma, X.
    Chen, Y.
    Hu, X.
    Tian, J.
    Zhu, X.
    Shi, Z.
    Du, X.
    Li, M.
    Liu, S.
    Yu, R.
    Zhao, J.
    Ma, Q.
    Xie, C.
    Li, Xiongbin
    Chen, T.
    Lin, Y.
    Zeng, Lizhen
    Ye, C.
    Ye, W.
    Luo, X.
    Zeng, Lingshan
    Yu, S.
    Guan, W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (10): : 923 - 935
  • [29] Prognostic impact of albuminuria in early-stage chronic kidney disease on cardiovascular outcomes: a cohort study
    Yaqoob, Khadija
    Naderi, Hafiz
    Thomson, Ross J.
    Aksentijevic, Dunja
    Jensen, Magnus T.
    Munroe, Patricia B.
    Petersen, Steffen E.
    Aung, Nay
    Yaqoob, Muhammed Magdi
    HEART, 2025,
  • [30] The Impact of Early-Stage Chronic Kidney Disease on Weight Loss Outcomes After Gastric Bypass
    Pereira, Joao
    Pereira, Pedro R.
    Andrade, Sara
    Pereira, Sofia S.
    Nora, Mario
    Guimaraes, Marta
    Monteiro, Mariana P.
    OBESITY SURGERY, 2023, 33 (12) : 3767 - 3777